LIVE

Serial Number

88489837

Owner

Alkermes Pharma Ireland Limited

Attorney

Norm J. Rich

First Use Date

Oct 11, 2021

Filing Date

Jun 26, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LYBALVI Trademark

Serial Number: 88489837 • Registration: 6913410

LYBALVI is a trademark filed by Alkermes Pharma Ireland Limited on June 26, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Alkermes Pharma Ireland Limited (87 trademarks)

Connaught House
Dublin 4 , IE

Entity Type: 99

Legal Representation

Attorney of Record

Norm J. Rich

2,984 trademarks filed View all →

Correspondence Address

Norm J. Rich FOLEY & LARDNER LLP

3000 K STREET, N.W.

SIXTH FLOOR

WASHINGTON, DC 20007

UNITED STATES

Trademark Details

Filing Date

June 26, 2019

Registration Date

November 29, 2022

First Use Anywhere

October 11, 2021

First Use in Commerce

October 15, 2021

Published for Opposition

October 29, 2019

Goods & Services

Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 24, 2026 ASCK

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 29, 2022 NRCC

REGISTERED-PRINCIPAL REGISTER

Nov 29, 2022 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 28, 2022 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 27, 2022 CNPR

ASSIGNED TO EXAMINER

Oct 17, 2022 DOCK

STATEMENT OF USE PROCESSING COMPLETE

Oct 4, 2022 SUPC

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 7, 2022 EXRA

SOU EXTENSION 4 GRANTED

Jan 6, 2022 EX4G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 28, 2021 AITU

USE AMENDMENT FILED

Dec 17, 2021 IUAF

SOU EXTENSION 4 FILED

Dec 17, 2021 EXT4

SOU TEAS EXTENSION RECEIVED

Dec 17, 2021 EEXT

TEAS STATEMENT OF USE RECEIVED

Dec 17, 2021 EISU

ASSIGNED TO EXAMINER

Oct 6, 2021 DOCK

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 25, 2021 EXRA

SOU EXTENSION 3 GRANTED

Mar 23, 2021 EX3G

SOU EXTENSION 3 FILED

Mar 23, 2021 EXT3

SOU TEAS EXTENSION RECEIVED

Mar 23, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 31, 2020 EXRA

SOU EXTENSION 2 GRANTED

Oct 29, 2020 EX2G

SOU EXTENSION 2 FILED

Oct 29, 2020 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 29, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 28, 2020 EXRA

SOU EXTENSION 1 GRANTED

Mar 26, 2020 EX1G

SOU EXTENSION 1 FILED

Mar 26, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 26, 2020 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 24, 2019 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 29, 2019 NPUB

PUBLISHED FOR OPPOSITION

Oct 29, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 9, 2019 NONP

ASSIGNED TO LIE

Sep 25, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 19, 2019 CNSA

EXAMINER'S AMENDMENT ENTERED

Sep 18, 2019 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 18, 2019 GNEN

EXAMINERS AMENDMENT E-MAILED

Sep 18, 2019 GNEA

EXAMINERS AMENDMENT -WRITTEN

Sep 18, 2019 CNEA

ASSIGNED TO EXAMINER

Sep 17, 2019 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jul 9, 2019 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 6, 2019 NWOS

NEW APPLICATION ENTERED

Jun 29, 2019 NWAP

Related Trademarks

More from this Owner

TELDAZIA

NEMCASGO

ARQIMLY

MURAL ONCOLOGY

More in Same Class